A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing (Q36711264)
Jump to navigation
Jump to search
scientific article published on 7 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing |
scientific article published on 7 January 2013 |
Statements
1 reference
A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing (English)
1 reference
Fadi Saade
1 reference
Yoshikazu Honda-Okubo
1 reference
Samay Trec
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference